News

PAX Institute is a mental health clinic destigmatizing alternative treatments for depression, anxiety, chronic pain or PTSD.
A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...
An antidepressant containing a form of the drug ketamine has been added to ... for the estimated 30,000 Australians with treatment-resistant depression. This is when a patient has tried multiple ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, ...
It’s the kind of thing that might most often be associated with the wild side of the Roaring Fork Valley. But ketamine, and ...
A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...
That's why today, ketamine is increasingly being used to treat a variety of illnesses, including depression, anxiety, ...
A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...
A mind-altering medication chemically akin to ketamine will be made cheaper to improve the lives of Australians suffering ...
NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine: Wilmington, Delaware Tuesday, May 6, 2025, 17:00 Hrs [IST] NRx Phar ...
An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...